跳至主要内容
临床试验/NCT01341093
NCT01341093已完成不适用

Educational Program With Telephone Follow-up for Patients After Percutaneous Coronary Intervention: Randomized Controlled Trial

University of Sao Paulo2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2011年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
2
主要终点
change from baseline in perceived health status at six months

研究概览

简要总结

The purpose of this study is to elaborate an educative program that includes telephone follow-up and assess its impact on the perceived health status of patients submitted to percutaneous coronary intervention.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients (18 years or more) of both sexes
  • Being submitted to the first coronary artery bypass graft surgery between April 2011 and July 2012
  • Having a properly functioning residential phone line

排除标准

  • No cognitive condition to participate (assessed through the Mini-Mental State Examination - MMSE)
  • Illiterate participants who did not reach the minimum score 13 on the MMSE
  • Participants with one to seven years of education who did not reach the minimum score 18 on the MMSE
  • Participants with eight or more years of education who did not reach the minimum of 26 points on the MMSE

结局指标

主要结局

change from baseline in perceived health status at six months

时间窗: baseline and six months

The questionnaire "Medical Outcomes Survey 36 - Item Short-Form" developed by Ware and Sherboune (1992) will be used to collect the data at baseline and at six months.

次要结局

  • change from baseline in self-efficacy at six months(baseline and six months)
  • change from baseline in anxiety and depression at six months(baseline and six months)
  • change from baseline in treatment adherence at six months(baseline and six months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Rejane Kiyomi Furuya

Ph.D

University of Sao Paulo

研究点 (2)

Loading locations...

相似试验

Education Program for Cardiac Patients | 临床试验